CITIGROUP INC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
CITIGROUP INC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$0
-100.0%
885
-34.9%
0.00%–
Q2 2022$1,000
-80.0%
1,359
-45.8%
0.00%–
Q1 2022$5,000
-87.2%
2,507
-73.4%
0.00%–
Q4 2021$39,000
+11.4%
9,437
+152.2%
0.00%–
Q3 2021$35,000
+34.6%
3,742
+161.1%
0.00%–
Q2 2021$26,000–1,433–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders